1. Home
  2. TTRX vs CTM Comparison

TTRX vs CTM Comparison

Compare TTRX & CTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$3.42

Market Cap

116.0M

Sector

Health Care

ML Signal

N/A

CTM

Castellum Inc.

HOLD

Current Price

$0.96

Market Cap

93.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTRX
CTM
Founded
2015
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
116.0M
93.7M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
TTRX
CTM
Price
$3.42
$0.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$8.00
$3.00
AVG Volume (30 Days)
17.3K
895.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
52.63
EPS
N/A
N/A
Revenue
N/A
$44,764,852.00
Revenue This Year
N/A
$23.00
Revenue Next Year
N/A
$11.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.57
$0.79
52 Week High
$5.98
$1.56

Technical Indicators

Market Signals
Indicator
TTRX
CTM
Relative Strength Index (RSI) 42.29 54.55
Support Level $2.64 $0.95
Resistance Level $5.12 $1.13
Average True Range (ATR) 0.23 0.05
MACD 0.02 0.01
Stochastic Oscillator 29.58 84.44

Price Performance

Historical Comparison
TTRX
CTM

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology company focused on developing pharmaceutical and medical device products for dermatology, wound care, and infectious disease. The company's proprietary platform technology, called PermaFusion, enhances drug performance by improving the stability and bioavailability of active pharmaceutical ingredients, which allows for reduced doses and fewer side effects. Its primary development programs target skin conditions such as moderate to severe eczema and onychomycosis.

About CTM Castellum Inc.

Castellum Inc is engaged in providing information technology services. The company provides financial services, healthcare, and other users of large data applications with services that include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and MBSE. In addition to constantly innovating and enhancing organic capabilities, Castellum is acquiring technology companies in the areas of cybersecurity, information technology, electronic warfare, information warfare, and information operations with businesses in the defense, federal, civilian, and commercial markets.

Share on Social Networks: